Related references
Note: Only part of the references are listed.Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential
Shi-Dong Ma et al.
JOURNAL OF VIROLOGY (2017)
Mouse model for acute Epstein-Barr virus infection
Tristan Wirtz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Hodgkin lymphoma: Pathology and biology
Stephan Mathas et al.
SEMINARS IN HEMATOLOGY (2016)
The biology and treatment of plasmablastic lymphoma
Jorge J. Castillo et al.
BLOOD (2015)
Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A
Takeharu Minamitani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma
Kamonwan Fish et al.
BLOOD (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
Baochun Zhang et al.
CELL (2012)
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Michael R. Green et al.
CLINICAL CANCER RESEARCH (2012)
Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (LMP1) and LMP2A Function Cooperatively To Promote Carcinoma Development in a Mouse Carcinogenesis Model
Kathy H. Y. Shair et al.
JOURNAL OF VIROLOGY (2012)
Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
Kathy H. Y. Shair et al.
MBIO (2012)
Epstein-Barr Virus LMP2A Reduces Hyperactivation Induced by LMP1 to Restore Normal B Cell Phenotype in Transgenic Mice
Alexandra C. Vrazo et al.
PLOS PATHOGENS (2012)
Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
Jing Ouyang et al.
BLOOD (2011)
CXCR3 ligands: redundant, collaborative and antagonistic functions
Joanna R. Groom et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation
Q. -F. Liu et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Highly Active Antiretroviral Therapy and the Incidence of Non-AIDS-Defining Cancers in People With HIV Infection
Thomas Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis
R. Bultema et al.
ONCOGENE (2009)
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis
Kathryn T. Bieging et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
EBV LMP2A affects LMP1-mediated NF-κB signaling and survival of lymphoma cells by regulating TRAF2 expression
Llaria Guasparri et al.
BLOOD (2008)
Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development
Kyongrim Kwon et al.
IMMUNITY (2008)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro
Michelle Swanson-Mungerson et al.
JOURNAL OF VIROLOGY (2006)
NF-κB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
SA Keller et al.
BLOOD (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma
M Teichmann et al.
JOURNAL OF PATHOLOGY (2005)
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo
LL Laichalk et al.
JOURNAL OF VIROLOGY (2005)
Role of NF-κB in cell survival and transcription of latent membrane protein 1 -: Expressing or Epstein-Barr virus latency III-infected cells
ED Cahir-McFarland et al.
JOURNAL OF VIROLOGY (2004)
B cell receptor signal strength determines B cell fate
S Casola et al.
NATURE IMMUNOLOGY (2004)
Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo
D Panagopoulos et al.
JOURNAL OF VIROLOGY (2004)
Epstein-Barr Virus (EBV) LNW2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma
T Portis et al.
BLOOD (2003)
LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways
M Merchant et al.
VIROLOGY (2001)
The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1
CW Dawson et al.
VIROLOGY (2001)
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
GJ Babcock et al.
IMMUNITY (2000)
Share Paper
